<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00199173</url>
  </required_header>
  <id_info>
    <org_study_id>Sir-Spheres1</org_study_id>
    <nct_id>NCT00199173</nct_id>
  </id_info>
  <brief_title>Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only</brief_title>
  <official_title>Comparison Hepatic Intra-arterial Injection of Yttrium-90 Versus 5FU in Colorectal Cancer Metastatic to the Liver Only</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jules Bordet Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jules Bordet Institute</source>
  <brief_summary>
    <textblock>
      This is a Phase III trial comparing hepatic intra-arterial injection of Yttrium-90
      microspheres (selective internal radiation [SIR] spheres) versus infusional intravenous (IV)
      5FU in colorectal cancer metastatic to the liver only and refractory to standard IV
      chemotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Colorectal Neoplasm</condition>
  <condition>Secondary Malignant Neoplasm of Liver</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SIR Spheres intra-arterial hepatic</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically proven colorectal adenocarcinoma, metastatic to the liver only.

          -  Failure of prior chemotherapy for advanced colorectal cancer.

          -  Adequate laboratory values of hematologic, renal and liver function

          -  World Health Organization (WHO) performance status (PS) &lt;= 2

          -  Written consent

        Exclusion Criteria:

          -  Pregnant or lactating patients

          -  Other tumor type than adenocarcinoma (leiomyosarcoma; lymphoma).

          -  Patients with cirrhosis or other chronic liver disease

          -  Thrombosis of the hepatic main artery of the portal vein

          -  Lung shunting &gt; 20% as determined by nuclear medicine breakthrough scan

          -  Patients with serum bilirubin &gt; 1.0 x upper limit of normal (ULN) or with AST and/or
             ALT and/or alkaline phosphatase &gt; 5 x ULN

          -  Patients with concurrent or within 4 week period administration of any other
             experimental drugs.

          -  Other serious illness or medical conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Hendlisz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jules Bordet Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jules Bordet Institute</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>February 23, 2011</last_update_submitted>
  <last_update_submitted_qc>February 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2011</last_update_posted>
  <responsible_party>
    <name_title>Institut Jules Bordet</name_title>
  </responsible_party>
  <keyword>colorectal cancer</keyword>
  <keyword>liver metastasis</keyword>
  <keyword>intraarterial hepatic injection</keyword>
  <keyword>yttrium loaded microspheres</keyword>
  <keyword>colorectal neoplasm metastatic to the liver</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

